Cadila is one of the top Active Pharmaceuticals Ingredient (API) manufacturing companies in the world, and one of the few pharmaceutical companies that is vertically-integrated with a very strong and independent positioning in both the API and the Formulations markets.
Spread over 80,000 sq. meter area, our API manufacturing facility at Ankleshwar, Gujarat is globally accredited by US FDA, ISO 9001:2008, COFEPRIS, PMDA Japan, EDQM Europe, TGA Australia, WHO Geneva, etc. Recognized as the world’s top API supplier, our cost competitiveness and quality obsession has been a critical influence in driving our profitability and growth in the formulations market as well.
Our diversified portfolio in APIs caters to over 90 countries. At present, we offer over 38 APIs and intermediates across various therapeutic categories – respiratory, diabetology, gastroenterology, pain management (antimigraine), orthopedics and many more. With 31 Drug Master Files and 12 Certificates of Suitability and many more in the pipeline, we are confident of building an unmatched API portfolio in the world.